Imprimis Fails To Nix Jury Award In Allergan False Ad Suit

Imprimis Pharmaceuticals has lost its bid in California federal court to overturn a $48,500 jury award in a case brought by Allergan USA Inc. accusing its rival of using false advertisements to trick doctors into thinking its eye-treatment drugs used FDA-approved ingredients…

Read this piece in its entirety at Law360.

Comments

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s